Go to Top

A group of Israeli Scientists from the Technion-Israel Institute of Technology (Haifa, Israel) has obteined important results using Biomedal´s “Anti-GSTT1 kit”.

A group of Israel Scientists from the Technion-Israel Institute of Technology (Haifa, Israel) has obtained important results using BIOMEDALl´s “Anti-GSTT1 ELISA Kit” in studies involving blood sera from children with congenital hemoglobinapathies that received a bone marrow transplantation.

The group has successfully expanded the potential applications of this kit, initially developed for diagnosing and monitoring liver graft rejection caused by a de novo autoimmune hepatitis. They have demostrated that after a bone marrow transplantation, the detection of anti-GSST1 antibodies in patients that are null for the GSTT1 gene may be predictive of granft rejection, thus allowing to control and adjust the immunosuppressive therapy.

This results have been published in bone Marrow Transplantation (see article).